Q2 2015 Holdings
Filed 2015-08-13 | 59 holdings | $175.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $39.9M | 1,380,320 | 22.8% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $38.9M | 2,605,361 | 22.2% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $33.8M | 1,913,153 | 19.3% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $27.6M | 1,545,410 | 15.7% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $27.5M | 1,719,945 | 15.7% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $3.5M | 1,142,676 | 2.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.1M | 27,300 | 0.7% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.1M | 9,900 | 0.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $1.1M | 2,600 | 0.6% |
| Axovant Sciences LTD | COM | G0750W104 | $101.9K | 5,000,000 | 0.1% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $88.1K | 9,945,997 | 0.1% |
| Dyax Corp | COM | 26746E103 | $71.6K | 2,703,093 | 0.0% |
| Sangamo Biosciences Inc(SGMO)Call | COM | 800677106 | $66.5K | 6,000,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $54.8K | 3,302,213 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K101 | $41.5K | 3,790,476 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $33.9K | 2,428,571 | 0.0% |
| Proteon Therapeutics Inc | COM | 74371L109 | $26.9K | 1,506,872 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $23.6K | 1,075,410 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $23.3K | 878,348 | 0.0% |
| Bellicum Pharmaceuticals Inc | COM | 079481107 | $21.8K | 1,026,402 | 0.0% |
| Medicines Co | COM | 584688105 | $20.2K | 705,925 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $18.4K | 109,383 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $17.9K | 766,000 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $16.0K | 1,141,333 | 0.0% |
| Novavax Inc | COM | 670002104 | $15.9K | 1,431,232 | 0.0% |
| Juno Therapeutics Inc | COM | 48205A109 | $14.9K | 280,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $13.8K | 1,600,000 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $13.5K | 1,220,209 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $13.5K | 749,000 | 0.0% |
| Therapeuticsmd Inc | COM | 88338N107 | $13.2K | 1,680,395 | 0.0% |
| Agile Therapeutics Inc(AGRXUSD) | COM | 00847L100 | $12.5K | 1,458,792 | 0.0% |
| Nivalis Therapeutics Inc | COM | 65481J109 | $11.5K | 757,263 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $10.2K | 246,645 | 0.0% |
| Alcobra LTD | SHS | M2239P109 | $10.0K | 1,525,894 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $10.0K | 668,406 | 0.0% |
| Tenax Therapeutics Inc | COM | 88032L100 | $9.9K | 2,670,300 | 0.0% |
| Sucampo Pharmaceuticals Inc | CL A | 864909106 | $7.4K | 450,000 | 0.0% |
| Arca Biopharma Inc | COM NEW | 00211Y209 | $6.5K | 5,678,592 | 0.0% |
| Auris MED Hldg AG | COM | H03579101 | $4.6K | 940,000 | 0.0% |
| Trevena Inc | COM | 89532E109 | $3.3K | 528,118 | 0.0% |
| T2 Biosystems Inc | COM | 89853L104 | $2.2K | 138,002 | 0.0% |
| Vical Inc | COM | 925602104 | $1.8K | 2,606,978 | 0.0% |
| Biota Pharmaceutials Inc | COM | 090694100 | $1.7K | 807,855 | 0.0% |
| Merrimack Pharmaceuticals in | COM | 590328100 | $1.4K | 116,400 | 0.0% |
| Tesaro Inc | COM | 881569107 | $1.4K | 23,500 | 0.0% |
| Newlink Genetics Corp | COM | 651511107 | $1.3K | 30,000 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $1.3K | 2,450 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $1.2K | 25,800 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.2K | 19,200 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $1.2K | 24,400 | 0.0% |